- SCAI Honors Members for Outstanding Service, Dedication May 14, 2015
- Real-World Data Show Prasugrel Is More Likely to Be Used in Low-Risk Patients May 8, 2015
- Short-Acting Antiplatelet Drug Cilostazol Safely Helps Patients Stop May 8, 2015
- Dr. James C. Blankenship Inducted as 39th SCAI President May 8, 2015
- Risk Algorithm Helps Interventional Cardiologists Identify Patients Who May Benefit From More Intensive Antiplatelet Medication May 8, 2015
SCAI Women in Innovations members hail from over 30 different countries around the world (represented on the map above). To learn more about the members of SCAI WIN, visit our member profile section HERE.
We are writing to invite you to participate in a brief survey on the management of Takotsubo Cardiomyopathy that we are conducting at New York University School of Medicine.
Takotsubo Cardiomyopathy is frequently diagnosed in patients who present with Acute Coronary Syndrome, and appears predominantly in the female population. These patients pose a significant dilemma for the clinician given the paucity of data to support decisions in the diagnosis and management of the disease. This survey intends to define current clinical practice, and demonstrate the areas needed for further research.
The survey should take no more than 5 minutes to complete. Please click on the link below to visit the survey website (or copy and paste the survey link into your internet browser).
Your participation in this survey is entirely voluntary and all of your responses will be anonymous. No personally identifiable information will be associated with your responses at any time. Should you have any further questions or comments, please feel free to contact me at Raymond.firstname.lastname@example.org.
We appreciate your time and consideration in completing this survey. It is only through the active participation of clinicians that we can define the current practices in the treatment of this syndrome.
Raymond Bietry MD
Fellow, Cardiovascular Disease
New York University School of Medicine
The WIN TAVI Registry enrolled its first patient! The patient (pictured left) is an 87 year-old active woman with aortic stenosis, prior medically treated NSTEMI, atrial fibrillation, and PM implantation due to an AV block. She was admitted to the hospital because of acute pulmonary edema and an echocardiogram showed a worsening of her aortic stenosis – the peak and mean aortic gradient were 60mmHg and 41mmHg respectively – and a LVEF of 20%. The logistic EuroSCORE and the EuroSCORE II were 18,92% and 10% respectively. The STS Score was 34.85%. The heart team at San Raffele Hospital in Milan, Italy discussed the case and because of the high operative risk, TAVI was agreed upon as the best treatement option. The patient was enrolled in WIN TAVI Registry and underwent transfemoral TAVI on March 8, 2013 with a CoreValve 26mm. There was no peri-procedural complication and the patient was discharged without event. We look forward to reporting updates from the WIN TAVI Registry as it continues to enroll.
It’s not just interventional cardiology. Women have made up just 14% of the top jobs in corporate America for the last 10 years running…. why are we stalling out? Sheryl Sandberg, COO of Facebook, believes she can make a difference through her new book and social media campaign titled “Lean In.” See more in the video interview below.
Is your hospital interested in starting a women’s heart program? Does your current program need to enhance educational and support options for your women heart patients? WIN Partner, WomenHeart’s National Hospital Alliance program offers hospitals the opportunity to enhance education and support services for their women heart patients through a collaborative effort with WomenHeart, the nation’s only patient centered organization supporting women living with heart disease. You can register today for an informational webinar, WomenHeart’s National Hospital Alliance: A Partnership in Progress for Women’s Heart Health, Thursday, February 28.